Leaders:
Carolyn Anderson
Executive Vice President of Intellectual Property, Technology Transfer, Contracts & Principal
Ms. Anderson is a Founder of BioAtla and President of Capia IP. Prior to founding BioAtla and CapiaIP, Ms. Anderson served as Vice President of Intellectual Property at Diversa Corporation for over 11 years. Ms. Anderson has a wide range of experience in intellectual property, licensing, technology transfer, contracts and business development.
Cathy Chang, PhD
Vice President of Scientific Projects & Collaboration
Dr. Chang is a Vice President at BioAtla. Prior to joining BioAtla, Dr. Chang held scientific management positions at Synthetic Genomics, Diversa Corporation, Stratagene, Digital Gene Technologies, Scripps Research Institute and the University of Southern California. Dr. Chang received her B.S. from the California Institute of Technology and her Ph.D. from Arizona State University and has in depth experience in molecular virology, gene discovery and synthesis, metagenomics, protein expression and purification.
Gerhard Frey, PhD
Vice President of Scientific Projects & Collaboration
Dr. Frey is Vice President, Bioatla. Prior to joining BioAtla, Dr. Frey managed several programs at Diversa Corporation and the University of Regensburg. Dr. Frey also received his Ph.D. from the University of Regenburg. Dr. Frey has scientific expertise in assay development, immunology, antibody engineering, microbiology and molecular biology.
Jay M. Short, PhD
Chairman, CEO & Principal
Dr. Short is a Founder of BioAtla and President of the E.O. Wilson Biodiversity Foundation. Formerly Dr. Short was Founder, Chief Executive Officer and Chief Technology Officer of Diversa Corporation and served in various senior management positions at Stratagene and Stratacyte. Dr. Short has extensive business experience in private and public biotech companies and scientific expertise in the fields of evolution and antibodies.
Leslie A. Hickle, PhD
Vice President of Business Development - San Diego, CA
Dr. Hickle has extensive experience in technical and business development innovation and leadership within biotech & growth-oriented companies. She has a B.S. in Biology and a Ph.D. in Entomology with a specialty in Toxicology from the University of California, Riverside.
Masood Tayebi, PhD
Business Advisor & Principal
Dr. Tayebi is a Founder of BioAtla and Executive Chairman of BioDuro. Prior to founding BioAtla and BioDuro and Chief Executive Officer of WFI, a leading global services firm. Dr. Tayebi has built and funded numerous companies creating market capitalization of nearly $10 billion.
Will A. DiSalvatore, JD.
Vice President of Business Development - New York, NY
Mr. DiSalvatore is a Vice President of BioAtla focusing on business development, strategic partnering and technology program implementation. He is an expert in life science business and transactions, intellectual property, and technology acquisition. Prior to BioAtla, Mr. DiSalvatore spent over 15 years in private legal practice.